About Syngene Overview Vision and Values Milestones Leadership team Quality and Certifications Awards Environment, Health, Safety & Sustainability Syngene Advantage Services Overview Discovery Chemistry Medicinal Chemistry Synthetic Chemistry Library Synthesis Biomolecules Computational Chemistry Organic Electronic Materials Peptide Synthesis Discovery Analytical Chemistry Discovery Biology Molecular Biology Protein Sciences Cell Line Development & Analysis Antibody Generation Screening & Assay Biology ADME/DMPK In vivo Pharmacology Genomics and Translational Biology Safety Assessment Exploratory/Discovery Toxicology Battery Of Genetic Toxicology Studies Acute, Sub Chronic and Chronic Studies Developmental and Reproductive Toxicology Studies Large Molecule Development Clone Development Cell Bank Preparation and Characterization Process Development Process Characterization Studies Formulation Development cGMP Manufacturing Analytical Characterization & Quality Control Stability Studies Biosimilar Development and Characterization Viral Testing Chemical Development Chemical Process Design, Development and Optimization Tech-Transfer Commercial Manufacturing High Potency APIs Process Analytical Research and Development Performance and Specialty Materials Formulation Development Pre-Formulation Toxicology Formulations Formulation Development Analytical Method Development and Validation Process Development and Scale-Up Clinical Supplies Stability Studies Method Development/Validation Structural Elucidation Reference & Working Standards Qualification Characterization Of Compounds Identification & Characterization Of Impurities Prep HPLC/Chiral Purification Residual Solvent Analysis Method Verifications/Transfer Stability Studies Phys-Chem Studies/5 Batch Analysis Polymer Research Biopolymers & Speciality Polymers Polymerization Process Development(GMP/Non-GMP) Polymer Characterization Analytical Method Development Production & Supply Polymers-Virgin Polymers(GMP/Non-GMP) Integrated Discovery & Development Small Molecule Discovery Small Molecule Development Biotherapeutics Discovery Biologics Development Clinical Development Services Human Pharmacology Studies Laboratory Services Clinical Trial Management Medical Writing and Medical Monitoring Services Regulatory Services Bioinformatics Data Annotation and Analysis The Heptox Platform Systems Biology and Quantitative Pharmacology NGS-Data-Analysis Software Platforms Antibody Drug Conjugates Oligonucleotide Synthesis Our Dedicated Centers Industries we serve Overview Pharmaceutical/Biotech Agrochemical Nutrition Animal Health Specialty & Performance Chemicals/Others Infrastructure Overview IT & Communication Discovery Chemistry Discovery Biology Safety Assessment Chemical Development Large Molecule Development Process R&D and cGMP Manufacturing Formulation Development Stability Services Polymer Research Clinical Development Services Careers Overview Life @ Syngene Influence Collaboration Build Meritocracy Institutionalise Learning Create environment to ‘live a full life’ Meet Our People Candidate Registration Candidate Login Jobs @ Syngene Media & Downloads Press Release Events Photo Gallery Video Gallery Virtual Tour Articles & Brochures Publications In the News White Papers / Blogs Investor Relations Overview Latest Report & Filings Subscribe Now Corporate Governance Board Of Directors Investor Event Calendar Investor Contact Archives CSR Overview Health Care Education Environmental Sustainability Rural Development Contact Us
Delivering High Quality Services From early discovery and development to clinical studies World class infrastructure and systems Talented pool of scientists and experienced management
Discovery Chemistry Syngene’s chemistry services can be availed on a standalone or integrated basis from milligram to kilogram scale..... Discovery Biology With wide-ranging capabilities in biology, we cater to a large customer base worldwide comprising biotechnology and pharmaceutical....... Safety Assessment Syngene’s experienced toxicology team is capable of identifying potential toxicity of a drug at an early stage..... Large Molecule Development Syngene provides end to end development services in biologics from cell line development ..... Formulation Development Syngene provides services in formulation development for oral solid as well as liquid dosage forms including injectable formulations. Stability Studies Syngene offers analytical services for both small and large molecules for discovery and development processes.... Polymer Research Syngene’s Polymer group supports high-quality custom synthesis and contract manufacturing services...... Integrated Discovery & Development Syngene provides a broad spectrum of integrated discovery and development services right .... Clinical Development Services Syngene’s CDS supports early through late phase (BA/BE, Phase l-lV) clinical development programs across a wide range of therapeutic areas Bioinformatics At Syngene, we offer integrated bioinformatics services to biotech and pharmaceutical Antibody Drug Conjugates Syngene’s Antibody Drug Conjugate (ADC) unit brings together an array of multidisciplinary capabilities in antibody generation.. Our Dedicated Centers Syngene's unique business model allows it to offer its services tailor made to its client's requirements.
Discovery Chemistry Syngene’s chemistry services can be availed on a standalone or integrated basis from milligram to kilogram scale.....
Discovery Biology With wide-ranging capabilities in biology, we cater to a large customer base worldwide comprising biotechnology and pharmaceutical.......
Safety Assessment Syngene’s experienced toxicology team is capable of identifying potential toxicity of a drug at an early stage.....
Large Molecule Development Syngene provides end to end development services in biologics from cell line development .....
Formulation Development Syngene provides services in formulation development for oral solid as well as liquid dosage forms including injectable formulations.
Stability Studies Syngene offers analytical services for both small and large molecules for discovery and development processes....
Polymer Research Syngene’s Polymer group supports high-quality custom synthesis and contract manufacturing services......
Integrated Discovery & Development Syngene provides a broad spectrum of integrated discovery and development services right ....
Clinical Development Services Syngene’s CDS supports early through late phase (BA/BE, Phase l-lV) clinical development programs across a wide range of therapeutic areas
Antibody Drug Conjugates Syngene’s Antibody Drug Conjugate (ADC) unit brings together an array of multidisciplinary capabilities in antibody generation..
Our Dedicated Centers Syngene's unique business model allows it to offer its services tailor made to its client's requirements.
14 Feb - 2019 ICICI Prudential 15 Feb - 2019 IIFL's Enterprising India Global Investors' Conference 06 Mar - 2019 11th Goldman Sachs India Pharma and Healthcare Tour
18 Mar - 2019 CPHI Japan March 18th - 20th, 2019. Tokyo, Japan 2B -24 Book a Meeting 08 Apr - 2019 Drug Discovery Chemistry April 8th - 12th, 2019. San Diego, CA 300 Book a Meeting 16 Apr - 2019 Bio-IT World Conference and Expo April 16th - 18th, 2019. Boston, MA 151 Book a Meeting 05 Aug - 2019 Immuno-Oncology Summit 2019 August 5th - 9th, 2019. Boston 5 Book a Meeting 12 Aug - 2019 Bioprocessing Summit August 12th - 16th, 2019. Boston, MA 314 Book a Meeting 19 Sep - 2019 Discovery on Target September 19th, 2019. Boston 306 Book a Meeting
16 Apr - 2019 Bio-IT World Conference and Expo April 16th - 18th, 2019. Boston, MA 151 Book a Meeting
Syngene records robust performance in Q3FY19 Syngene Q2 FY19 revenue up 24% to Rs. 437 Cr Notice of Management Change Syngene Posts Strong Revenue Growth in Q1 FY19 Revenue up 38% to Rs. 425 Cr Syngene International Expands Collaboration with Baxter Syngene International Announces Partnership with Zumutor Biologics for Biotherapeutic Antibody Discovery Services Syngene Delivers Strong Revenue Momentum Syngene International Signs R&D Agreement with GSK Syngene Q3 FY18 Revenue up 15% to Rs. 399 Cr Bristol-Myers Squibb and Syngene International Expand Ongoing Research Collaboration Syngene Growth Picks Up in Q2 FY18 Syngene Q1 FY18 Revenue up 6% to Rs. 308 Cr Syngene International Announces Broadening of Research Collaboration with Amgen Inc. Expands Dedicated R&D Center Syngene Delivers 14% Revenue Growth in FY17 Herbalife Nutrition Partners with Syngene to Establish Nutrition Research and Development Lab in India Syngene Q3 Revenue up by 23% Fire Incident at Syngene Facility Syngene registers strong top and bottom line growth in Q2 FY17 Syngene International closes deal with Strand Life Sciences to Purchase Systems Biology and Pharma Services Practice Syngene International Commissions Dedicated R&D Center for Amgen Syngene’s Robust Growth Continues in Q1 FY17 Syngene delivers sustained growth in Q4 FY16 Syngene growth momentum continues with robust Q3 FY16 delivery Syngene appoints Jonathan Hunt as CEO-designate Syngene delivers broad based growth of 28% in H1 FY16 Syngene International lists at Rs 295 on BSE; NSE; closes at a premium of 24% at Rs 310.55 on Listing day Syngene International IPO oversubscribed 31 times Syngene International gets RoC approval for its RHP Silver Leaf Oak acquires 10% stake in Syngene International, Biocon’s Research Services Subsidiary Bristol-Myers Squibb and Syngene International Extend Research Collaboration Shri Ghulam Nabi Azad Inaugurates Baxter Global Research Center at Syngene GE Capital to invest in Syngene, Biocon’s Research Services Subsidiary Abbott inaugurates First Nutrition Research and Development Center in India in collaboration with Syngene Syngene and Endo to expand their collaboration in cancer research Syngene and DuPont Crop Protection Forge Alliance Partnership Syngene partners with Sapient Discovery to expand integrated drug discovery offerings Biocon's Syngene enters into research partnership with Bristol-Myers Squibb Syngene International and Innate Pharmaceuticals collaborate to develop virulence blockers Syngene enters into research agreement with Novartis Institute for Biomedical Research Inc.
Syngene International Announces Partnership with Zumutor Biologics for Biotherapeutic Antibody Discovery Services
Syngene International Announces Broadening of Research Collaboration with Amgen Inc. Expands Dedicated R&D Center
Herbalife Nutrition Partners with Syngene to Establish Nutrition Research and Development Lab in India
Syngene International closes deal with Strand Life Sciences to Purchase Systems Biology and Pharma Services Practice
Syngene International lists at Rs 295 on BSE; NSE; closes at a premium of 24% at Rs 310.55 on Listing day
Abbott inaugurates First Nutrition Research and Development Center in India in collaboration with Syngene